EnBio Holdings, Inc.

EnBio Holdings, Inc.

TTSE:6092
618.00
JPY
-29.00
(-4.48%)
6.19BMarket Cap
Feb 15Next Earn

Total Valuation

JPY

As of March 31, 2026, EnBio Holdings, Inc. carries a market capitalization of 6.19B, placing it among publicly traded companies globally. Its enterprise value stands at 12.89B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap6.19B
Enterprise Value12.89B

Important Dates

EnBio Holdings, Inc.'s next confirmed earnings release is scheduled for February 15, 2027.

Earnings Date2/15/2027

Share Statistics

As of March 31, 2026, EnBio Holdings, Inc. has 8.12M shares outstanding.

Shares Outstanding8.12M

Valuation Ratios

These figures are as of March 31, 2026.

PB Ratio0.67
P/TBV Ratio0.70

Financial Position

As of March 31, 2026, EnBio Holdings, Inc. maintains a current ratio of 2.20, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities.

Current Ratio2.20
Quick Ratio0.78
Debt / Equity114.25

Financial Efficiency

These figures cover the twelve months ended March 31, 2026.

Employee Count104.00

Stock Price Statistics

JPY

As of the close on November 17, 2026, EnBio Holdings, Inc.'s stock has gained approximately 3.00% over the past 52 weeks. The 50-day moving average sits at 776.98, while the 200-day moving average is 757.00.

52-Week Price Change3.00%
50-Day Moving Average776.98
200-Day Moving Average757.00

Balance Sheet

JPY

As of March 31, 2026, EnBio Holdings, Inc. holds 4.04B in cash and equivalents against 10.65B in total debt, resulting in a net debt position of 6.62B. Total book value stands at 9.25B, with working capital of 6.23B providing operational flexibility.

Cash & Cash Equivalents4.04B
Total Debt10.65B
Net Debt6.62B
Equity (Book Value)9.25B
Book Value Per Share1,139.01
Working Capital6.23B